Skip to content

Real-time Comparison of Left Ventricular Strokevolume Measurement by Four Different Methods

Real-time Comparison of Left Ventricular Strokevolume Measurement by Four Different Methods

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01791283
Acronym
FourComp
Enrollment
20
Registered
2013-02-13
Start date
2012-08-31
Completion date
2013-02-28
Last updated
2013-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Difference in Measured Results Using Four Different Strokevolume Measurements Simultaneously.

Keywords

Left ventricular stroke volume, Arterial waveform analysis, Esofageal doppler, Ultrasound, Cardiac magnetic Imaging, Limits of agreement

Brief summary

Real-time comparison of three different bedside strokevolumemeasurements (arterial waveform analysis, eosofageal doppler and 2D transthoracal ultrasound) validated against cardiac magnetic resonance imaging (CMRI)

Detailed description

20 healthy volounteers between age of 20-40 years, no previous medical history undergo simoultaneous left ventrikular strokevolume measurements using three different methods at rest. After datasampling and without moving, the subject then undergo Cardiac Magnetic Resonance Imaging with 2D-throughplane and cine tecnology for validation of volume measurements. The data is then analyzed using Bland-Altman calculation.

Interventions

PROCEDUREArterial waveform analysis, esofageal doppler, transthoracal cardiac ultrasound, Cardiac magnetic resonance imaging.

Sponsors

University Hospital, Linkoeping
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy volounteers age 20-40, BMI \< 30, weight \< 100 kg, no medications, sinus rythm on ECG, no contra-indications for MRI, ability to give written informed consent. \-

Exclusion criteria

* Heart and/or vascular disease such as angina pectoris, arrythmias, claudicatio intermittens e g. * Diseases in gastrointestinal tract or nose. * Coagulopathies * Pregnancy * Allergys for local anaesthetics * Claustrofobia

Design outcomes

Primary

MeasureTime frame
Limits of agreement (LOA) is less than 30% using CMRI as validation for each individual measurement of left ventricular stroke volume.Study period (1 month)

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026